Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Kyntra Bio Inc maintains a gross margin of 105.39%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -499.07%, while the net margin is -1221.75%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively KYNB converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, KYNB competes directly with industry leaders such as AYTU and AEON. With a market capitalization of $28.80M, it holds a leading position in the sector. When comparing efficiency, KYNB's gross margin of 105.39% stands against AYTU's 59.99% and AEON's N/A. Such benchmarking helps identify whether Kyntra Bio Inc is trading at a premium or discount relative to its financial performance.
